Drreddys Laboratories reported INR67.7B in Sales Revenues for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ani Pharmaceuticals ANIP:US USD 83.82M 9.97M
Aurora Cannabis Inc ACB:CN CAD 49.26M 952K
Bayer BAYN:GR EUR 11.28B 1.54B
Canopy Growth Corp WEED:CN CAD 117.86M 7.75M
Catalent CTLT:US USD 1.02B 291M
Cipla CIPLA:IN INR 58.1B 184.5M
Corcept Therapeutics CORT:US USD 101.73M 1.66M
Drreddys Laboratories RDY:US INR 67.7B 4.64B
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
GlaxoSmithKline GSK:LN GBP 7.83B 685.07B
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Horizon Pharma HZNP:US USD 925.36M 48.95M
Lannett LCI:US USD 75.08M 890K
Novartis NOVN:VX USD 12.84B 243M
Pacira Pharmaceuticals PCRX:US USD 167.47M 1.94M
Phibro Animal Health PAHC:US USD 232.52M 22.74M
Prestige Brands PBH:US USD 289.27M 12.21M
Richter Gedeon RICHT:HB HUF 217.81B 24.88B
Supernus Pharmaceuticals SUPN:US USD 177.35M 7.3M
Teva Pharmaceutical TEVA:IT USD 3.6B 191M